http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0626381-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5c450bfedfc111b05db4c1419c3c70a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-52
filingDate 1993-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_694322aae3c6654bbafb509d33acfd6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_148d42eefd424f82eb9d031325cc9040
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c905b6eb34f017dddc1480dd1530867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_589cb6f1335faea9c3d3e0b3a65cabba
publicationDate 1994-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0626381-A1
titleOfInvention Preparation of form 1 ranitidine hydrochloride
abstract Pure Form 1 ranitidine hydrochloride is prepared by a process of crystallization from a solution of ranitidine hydrochloride in a mixed solvent comprising 1 part by volume of at least one lower alkanol such as ethanol and 1 - 2.0 parts by volume of a Cā‚† - Cā‚ā‚€ aromatic hydrocarbon such as toluene, and in the presence of seed crystals of pure Form 1 ranitidine hydrochloride. In the preferred process according to the invention, the ranitidine hydrochloride is prepared in situ in the solvent mixture by adding hydrochloric acid to a solution of the free base in the solvent mixture, in the presence of the seed crystals.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2942058-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0859768-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2929884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015155297-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0859768-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5621120-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9619232-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0694540-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6855835-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6815548-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0164662-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015169957-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1394160-A1
priorityDate 1993-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2084580-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3001055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID47909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6603542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9883333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129307185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226419996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226419995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048

Total number of triples: 48.